{
  "ptid_time": "002_S_5256_2013-07-15",
  "img_path": "/data/qiuhui/data/adni/images/002_S_5256/2013-07-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 21,299 mm³, 24.1% below the reference mean. With a Z-score of -0.55 (29.0th percentile), this represents normal volume ; hippocampal volume measures 7,727 mm³, 8.6% above the reference mean. With a Z-score of 0.79 (78.5th percentile), this represents normal volume ; whole brain volume measures 1,017,140 mm³, 4.4% above the reference mean. With a Z-score of 0.55 (70.8th percentile), this represents normal volume ; entorhinal cortex volume measures 4,239 mm³, 15.4% above the reference mean. With a Z-score of 0.95 (82.8th percentile), this represents normal volume ; fusiform gyrus volume measures 17,895 mm³, 5.2% above the reference mean. With a Z-score of 0.47 (68.1th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,856 mm³, 3.6% above the reference mean. With a Z-score of 0.31 (62.2th percentile), this represents normal volume . ",
  "text_data": "Age is 70.4 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Alcohol Abuse; Smoking; Major Surgical Procedures. MMSE: 30.0. MoCA: 28.0. Logical Memory: 18.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.31 SUVR (moderate elevated); Amyloid beta: 923.30 pg/mL (normal ); Total tau: 393.80 pg/mL (moderate elevated); Phosphorylated tau: 36.38 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "Reasoning: The brain volumes (hippocampus, entorhinal cortex, fusiform gyrus, etc.) are all within normal ranges, and cognitive scores (MMSE 30, MoCA 28) are intact. However, moderate elevations in T-tau, P-tau, and AV45 suggest possible early neurodegenerative changes despite normal Aβ.  \nDiagnosis: **CN (Cognitively Normal)**  \nConfidence: **Medium** (Biomarkers indicate pathology, but cognitive and structural measures remain normal—consistent with preclinical AD or non-AD tauopathy.)  \n\n*Note: If longitudinal data shows cognitive decline, re-evaluation for MCI would be warranted.*",
  "timestamp": "2025-07-25T20:35:17.410605"
}